January 26, 2022: PCT Grand Rounds to Highlight Primary Results of EMBED Trial

Headshots of Dr. Edward Melnick and Dr. Gail D'Onofrio
Dr. Edward Melnick and Dr. Gail D’Onofrio, co–principal investigators of EMBED

In this Friday’s PCT Grand Rounds, the principal investigators of EMBED, an NIH Collaboratory Trial, will announce the study’s primary results.

Co–principal investigators Dr. Edward Melnick and Dr. Gail D’Onofrio of Yale University will present “EMBED Trial Results: Pragmatic Trial of User-Centered Clinical Decision Support to Implement Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.” The Grand Rounds session will be held on Friday, January 28, at 1:00 pm eastern.

EMBED is a pragmatic trial to evaluate the effect of user-centered computerized clinical decision support on rates of emergency department–initiated buprenorphine and referral for ongoing medication-assisted treatment for patients with opioid use disorder.

Join the online meeting.

EMBED is supported within the NIH Collaboratory by the NIH Common Fund and by a cooperative agreement from the National Institute on Drug Abuse.